Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients
This article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected patt...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/1/58 |
| _version_ | 1797342989415088128 |
|---|---|
| author | Vaida Averjanovaitė Lina Gumbienė Ingrida Zeleckienė Virginija Šileikienė |
| author_facet | Vaida Averjanovaitė Lina Gumbienė Ingrida Zeleckienė Virginija Šileikienė |
| author_sort | Vaida Averjanovaitė |
| collection | DOAJ |
| description | This article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected pattern of decline in pulmonary function parameters. The complexity of PH associated with ILD (PH-ILD) diagnostics is emphasized by the limitations of transthoracic echocardiography in the ILD population, necessitating the exploration of alternative diagnostic approaches. Cardiac magnetic resonance imaging (MRI) emerges as a promising tool, offering insights into hemodynamic parameters and providing valuable prognostic information. The potential of biomarkers, alongside pulmonary function and cardiopulmonary exercise tests, is explored for enhanced diagnostic and prognostic precision. While specific treatments for PH-ILD remain limited, recent studies on inhaled treprostinil provide new hope for improved patient outcomes. |
| first_indexed | 2024-03-08T10:41:10Z |
| format | Article |
| id | doaj.art-4d3243eddf76417eb025c6da1d3edebe |
| institution | Directory Open Access Journal |
| issn | 1010-660X 1648-9144 |
| language | English |
| last_indexed | 2024-03-08T10:41:10Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-4d3243eddf76417eb025c6da1d3edebe2024-01-26T17:35:07ZengMDPI AGMedicina1010-660X1648-91442023-12-016015810.3390/medicina60010058Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease PatientsVaida Averjanovaitė0Lina Gumbienė1Ingrida Zeleckienė2Virginija Šileikienė3Faculty of Medicine, Vilnius University, LT-03101 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, LithuaniaFaculty of Medicine, Vilnius University, LT-03101 Vilnius, LithuaniaClinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, LithuaniaThis article provides a comprehensive overview of the latest literature on the diagnostics and treatment of pulmonary hypertension (PH) associated with interstitial lung disease (ILD). Heightened suspicion for PH arises when the advancement of dyspnoea in ILD patients diverges from the expected pattern of decline in pulmonary function parameters. The complexity of PH associated with ILD (PH-ILD) diagnostics is emphasized by the limitations of transthoracic echocardiography in the ILD population, necessitating the exploration of alternative diagnostic approaches. Cardiac magnetic resonance imaging (MRI) emerges as a promising tool, offering insights into hemodynamic parameters and providing valuable prognostic information. The potential of biomarkers, alongside pulmonary function and cardiopulmonary exercise tests, is explored for enhanced diagnostic and prognostic precision. While specific treatments for PH-ILD remain limited, recent studies on inhaled treprostinil provide new hope for improved patient outcomes.https://www.mdpi.com/1648-9144/60/1/58pulmonary hypertensioninterstitial lung diseasecardiopulmonary exercise testinglung function testsechocardiographycardiac magnetic resonance imaging |
| spellingShingle | Vaida Averjanovaitė Lina Gumbienė Ingrida Zeleckienė Virginija Šileikienė Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients Medicina pulmonary hypertension interstitial lung disease cardiopulmonary exercise testing lung function tests echocardiography cardiac magnetic resonance imaging |
| title | Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients |
| title_full | Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients |
| title_fullStr | Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients |
| title_full_unstemmed | Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients |
| title_short | Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients |
| title_sort | unmasking a silent threat improving pulmonary hypertension screening methods for interstitial lung disease patients |
| topic | pulmonary hypertension interstitial lung disease cardiopulmonary exercise testing lung function tests echocardiography cardiac magnetic resonance imaging |
| url | https://www.mdpi.com/1648-9144/60/1/58 |
| work_keys_str_mv | AT vaidaaverjanovaite unmaskingasilentthreatimprovingpulmonaryhypertensionscreeningmethodsforinterstitiallungdiseasepatients AT linagumbiene unmaskingasilentthreatimprovingpulmonaryhypertensionscreeningmethodsforinterstitiallungdiseasepatients AT ingridazeleckiene unmaskingasilentthreatimprovingpulmonaryhypertensionscreeningmethodsforinterstitiallungdiseasepatients AT virginijasileikiene unmaskingasilentthreatimprovingpulmonaryhypertensionscreeningmethodsforinterstitiallungdiseasepatients |